RYBOX
Price
$76.62
Change
+$0.13 (+0.17%)
Updated
Sep 11 closing price
Net Assets
129.02M
SHSAX
Price
$62.92
Change
-$0.10 (-0.16%)
Updated
Sep 11 closing price
Net Assets
6.17B
Interact to see
Advertisement

RYBOX vs SHSAX

RYBOX vs SHSAX Comparison Chart in %
View a ticker or compare two or three
VS
RYBOX vs. SHSAX commentary
Sep 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYBOX is a Hold and SHSAX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
SHSAX has more cash in the bank: 6.17B vs. RYBOX (129M). SHSAX pays higher dividends than RYBOX: SHSAX (0.26) vs RYBOX (0.00). RYBOX was incepted earlier than SHSAX: RYBOX (22 years) vs SHSAX (27 years). RYBOX (1.68) is less costly to investors than SHSAX (1.09). RYBOX is a more actively managed with annual turnover of: 75.00 vs. SHSAX (43.00). SHSAX initial investment is less costly to investors than RYBOX (5%) vs RYBOX (5%). SHSAX has a lower initial minimum investment than RYBOX: SHSAX (1000) vs RYBOX (2500). RYBOX annual gain was more profitable for investors over the last year : 24.74 vs. SHSAX (4.10). SHSAX (-17.90) and RYBOX (-18.51) have equivalent 5 years return.
RYBOXSHSAXRYBOX / SHSAX
Total Expense Ratio1.631.09150%
Annual Report Gross Expense Ratio1.681.09154%
Fund Existence22 years27 years-
Gain YTD23.931-2.642-906%
Front Load5%5%90%
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets129M6.17B2%
Annual Yield % from dividends0.000.26-
Returns for 1 year24.744.10603%
Returns for 3 years28.60-2.23-1,281%
Returns for 5 years-18.51-17.90103%
Returns for 10 years7.7034.8022%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRT257.068.93
+3.60%
Vertiv Holdings Co
EXP185.121.35
+0.73%
Eagle Materials
MNKD3.75-0.04
-1.06%
MannKind Corp
LTRN1.71-0.05
-2.84%
Lantern Pharma
RNAC8.19-0.24
-2.85%
Cartesian Therapeutics